{"id":3049,"date":"2018-10-03T17:52:52","date_gmt":"2018-10-03T15:52:52","guid":{"rendered":"http:\/\/oncomatryx.com\/?p=3049"},"modified":"2018-10-03T17:52:52","modified_gmt":"2018-10-03T15:52:52","slug":"nueva-cita-esmo-congress-2018","status":"publish","type":"post","link":"https:\/\/oncomatryx.com\/es\/nueva-cita-esmo-congress-2018\/","title":{"rendered":"Presentaci\u00f3n Poster en el Congreso ESMO 2018"},"content":{"rendered":"

Oncomatryx estar\u00e1 present\u00e9 en el Congreso de la Sociedad Europea de Ondocolog\u00eda M\u00e9dica en Munich<\/p>\n

\"ESMO<\/p>\n

ESMO 2018 Congress<\/span><\/h1>\n

Munich, Germany – 19 Oct – 23 Oct 2018<\/span><\/h2>\n

 <\/p>\n

La Dra. Myriam Fabre (Oncomatryx R&D Director)\u00a0 presenta el poster:<\/h4>\n

OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments<\/strong><\/h3>\n

Myriam Fabre1,6, Cristina Ferrer1, Saioa Dom\u00ednguez-Hormaetxe1, Roland Kontermann2, Klaus Pfizenmaier2, Oliver Seifert2, Pedro P. L\u00f3pez-Casas3, Muhammad Abbas4, Wolfgang Richter4, Laureano Simon1, Manuel Hidalgo5.<\/p>\n

 <\/p>\n

Si tambi\u00e9n va a asistir, y quiere que nos veamos, puede escribirnos un email mediante\u00a0el formulario adjunto<\/em><\/h4>\n

[contact-form-7 id=\u00bb804″ title=\u00bbPRO appointment\u00bb]<\/p>\n","protected":false},"excerpt":{"rendered":"

Oncomatryx estar\u00e1 present\u00e9 en el Congreso de la Sociedad Europea de Ondocolog\u00eda M\u00e9dica en Munich ESMO 2018 Congress Munich, Germany – 19 Oct – 23 Oct 2018   La Dra. Myriam Fabre (Oncomatryx R&D Director)\u00a0 presenta el poster: OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments Myriam … Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":3,"featured_media":3130,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-3049","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/3049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/comments?post=3049"}],"version-history":[{"count":0,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/3049\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/media?parent=3049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/categories?post=3049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/tags?post=3049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}